Create Alert
Watchlist

Novartis India

₹800.55
0.00 (0.00%) 1D
BSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
804.45
Prev. Close
800.55
Volume
30,142
Total traded value
2.41 Cr
Upper Circuit
960.65
Lower Circuit
640.45

Fundamentals

Market Cap₹1,977Cr
ROE13.75%
P/E Ratio(TTM)18.54
EPS(TTM)43.17
P/B Ratio2.55
Dividend Yield3.12%
Industry P/E40.22
Book Value313.91
Debt to Equity0.01
Face Value5
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Novartis India

Novartis India Limited is a pharmaceutical company dedicated to improving healthcare for patients by operating solely within the pharmaceuticals business segment throughout India. Its core mission is to reimagine medicine, leveraging economic growth and technological advancements to deliver solutions that improve and extend people's lives. The company's work is fundamentally grounded in science but is equally driven by empathy, focusing on transformative health milestones for patients across its therapeutic areas. It manages a diverse portfolio of 24 brands spanning key areas such as Transplant, Established Medicines, Neurosciences, and Oncology to address complex health conditions. A key strategy involves partnering with Dr. Reddy's Laboratories, which combines scientific innovation with large-scale operational capacity to expand market access for its medicines. In 2024 alone, the company supported over 2,400 patients through its transplant immunology brands Certican® and Simulect®, demonstrating its impact in life-saving therapies.;
Parent OrganisationNovartis India Limited
Managing DirectorMr. Sanjay Murdeshwar
Founded1947
BSE Symbol500672

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
70.68%
Retail And Others
28.60%
Other Domestic Institutions
0.53%
Foreign Institutions
0.19%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.25
Emcure Pharmaceuticals
NA
(0.00%)
33.30
Wockhardt
NA
(0.00%)
-427.29
Cohance Lifesciences
NA
(0.00%)
65.51
2025
28
Oct
Quarterly Result
Release date
29
Jul
Quarterly Result
Release date

23
Jul
Dividend
Ex date
₹25.00
per share

For each share you hold, you will receive ₹25.00
Dividend amount₹25.00 per share
Dividend TypeFinal
Ex Date23 Jul ‘25
Record Date23 Jul ‘25
Announcement date9 May ‘25

9
May
Dividend
Announced
₹25.00
per share

For each share you hold, you will receive ₹25.00
Dividend amount₹25.00 per share
Dividend TypeFinal
Ex Date23 Jul ‘25
Record Date23 Jul ‘25
Announcement date9 May ‘25
9
May
Annual Result
Release date
28
Jan
Quarterly Result
Release date
2024
25
Oct
Quarterly Result
Release date
29
Jul
Quarterly Result
Release date

23
Jul
Dividend
Ex date
₹25.00
per share

For each share you hold, you will receive ₹25.00
Dividend amount₹25.00 per share
Dividend TypeFinal
Ex Date23 Jul ‘24
Record Date24 Jul ‘24
Announcement date10 May ‘24

10
May
Dividend
Announced
₹25.00
per share

For each share you hold, you will receive ₹25.00
Dividend amount₹25.00 per share
Dividend TypeFinal
Ex Date23 Jul ‘24
Record Date24 Jul ‘24
Announcement date10 May ‘24
10
May
Annual Result
Release date
Events calendar
View upcoming events in other stocks